In addition, our work has elucidated the context-dependent oncogenic/tumor-suppressive function of BAP1 and highlighted the potential of therapeutically attenuating PRC1 activity in BAP1-deficient cold tumors. This evidence concerns the gene BAP1 and neoplasm.